Literature DB >> 8352614

Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany.

B Rzany, M Mockenhaupt, U Stocker, O Hamouda, E Schöpf.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8352614

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  15 in total

Review 1.  The significance of oral health in HIV disease.

Authors:  I L Chapple; J Hamburger
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

Review 2.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

3.  HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.

Authors:  Paola Borgiani; Davide Di Fusco; Fulvio Erba; Maria C Marazzi; Sandro Mancinelli; Giuseppe Novelli; Leonardo Palombi; Cinzia Ciccacci
Journal:  Eur J Clin Pharmacol       Date:  2013-12-10       Impact factor: 2.953

4.  Cutaneous manifestations of human immunodeficiency virus: a clinical update.

Authors:  Kirstin Altman; Erin Vanness; Ryan P Westergaard
Journal:  Curr Infect Dis Rep       Date:  2015-03       Impact factor: 3.725

5.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 6.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

7.  Severe antiretroviral therapy-induced toxic epidermal necrolysis in a child.

Authors:  Joseph M Norris; Laura H Stuttaford; Lyn F Dowds
Journal:  Case Rep Dermatol       Date:  2012-02-08

Review 8.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

Review 9.  Severe drug eruptions revisited.

Authors:  Sebastien Calbo
Journal:  Immunol Res       Date:  2012-09       Impact factor: 4.505

Review 10.  A complex interaction between drug allergy and viral infection.

Authors:  Tetsuo Shiohara; Yoko Kano
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.